Elevance Health Projects Cautious Medicaid Enrollment

Elevance Health Sets Conservative 2026 Medicaid Guidance

Wolfe Research reports that Elevance Health (NYSE:ELV) has established the most conservative guidance for Medicaid enrollment in 2026, projecting a decline of 8%. This assessment follows an updated analysis of state-level Medicaid membership data, which indicates a consistent pattern of attrition.

Overall Enrollment Trends

The latest data from March and April shows a continued reduction in Medicaid enrollment. States reporting through March saw a 72 basis point decline, an acceleration from previous months. For a portion of states providing April data, enrollment decreased by 37 basis points. Notably, Arkansas and Indiana saw the sharpest month-over-month drops at -2.0%, while New Jersey reported growth.

Impact on Major Insurers

Wolfe Research estimates year-to-date enrollment declines across the sector, including -1.9% for Centene (NYSE:CNC), -1.8% for CVS Health (NYSE:CVS), and -1.7% for Elevance Health. In response to these trends, Molina Healthcare (NYSE:MOH) has revised its attrition guidance higher to 6%, aligning with projections from Centene and Elevance.

Summary

While major Medicaid providers have indicated stabilizing trends during first-quarter discussions, they also noted that funding rates are running below historical trends. UnitedHealth (NYSE:UNH) specifically characterized current funding as insufficient, highlighting a key challenge for the industry moving forward.

FAQ

Q: Which company holds the most conservative Medicaid enrollment guidance for 2026?
A: According to Wolfe Research, Elevance Health has the most conservative guidance at negative 8%.

Q: What is the current trend for Medicaid enrollment?
A: Medicaid enrollment is experiencing a consistent decline across most states, with attrition rates accelerating in recent months.

Source: Investing.com